Vimarsana.com

Latest Breaking News On - Livanova - Page 1 : vimarsana.com

Robert W. Baird Boosts LivaNova (NASDAQ:LIVN) Price Target to $66.00

LivaNova (NASDAQ:LIVN – Free Report) had its price objective raised by Robert W. Baird from $58.00 to $66.00 in a research note published on Thursday morning, Benzinga reports. Robert W. Baird currently has a neutral rating on the stock. A number of other equities research analysts also recently issued reports on the company. StockNews.com upgraded […]

New-york
United-states
Louisiana
Robertw-baird
Barclays
Needham-company
Principal-financial-group-inc
Free-report
Moderate-buy
Get-free-report
Financial-markets

Robert W. Baird Raises LivaNova (NASDAQ:LIVN) Price Target to $66.00

LivaNova (NASDAQ:LIVN – Free Report) had its price target raised by Robert W. Baird from $58.00 to $66.00 in a research report sent to investors on Thursday, Benzinga reports. Robert W. Baird currently has a neutral rating on the stock. LIVN has been the topic of several other reports. Needham & Company LLC reiterated a […]

Louisiana
United-states
Zurcher-kantonalbank-zurich-cantonalbank
Robertw-baird
Barclays
Livanova-company-profile
Nasdaq
Vanguard-group-inc
Needham-company
Free-report
Moderate-buy
Get-free-report

LivaNova's (LIVN) "Buy" Rating Reiterated at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of LivaNova (NASDAQ:LIVN – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a $72.00 price objective on the stock. A number of other research analysts also recently commented on the company. Robert W. […]

Zurcher-kantonalbank-zurich-cantonalbank
Robertw-baird
Nasdaq
Needham-company
Barclays
Emerald-advisers
Mirae-asset-global-investments-co
Free-report
Moderate-buy
Get-free-report
Kantonalbank-zurich-cantonalbank
Asset-global-investments

Needham & Company LLC Reiterates "Buy" Rating for LivaNova (NASDAQ:LIVN)

Needham & Company LLC restated their buy rating on shares of LivaNova (NASDAQ:LIVN – Free Report) in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a $72.00 target price on the stock. Several other equities analysts also recently issued reports on the stock. Barclays lifted their price target on shares […]

Robertw-baird
Ameriprise-financial-inc
Dimensional-fund-advisors
Barclays
Greenlight-capital-inc
Needham-company
Primecap-management-co
Vanguard-group-inc
Free-report
Moderate-buy
Get-free-report

LivaNova (NASDAQ:LIVN) Updates FY 2024 Earnings Guidance

LivaNova (NASDAQ:LIVN – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share guidance of 3.050-3.150 for the period, compared to the consensus earnings per share estimate of 3.000. The company issued revenue guidance of $1.2 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. LivaNova […]

Robertw-baird
Needham-company
Barclays
Livanova-company-profile
Get-free-report
Moderate-buy
Advanced-circulatory-support
Livanova-daily
Livanova
Nasdaq-livn
Livn

LivaNova (NASDAQ:LIVN) Issues FY24 Earnings Guidance

LivaNova (NASDAQ:LIVN – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $3.05-3.15 for the period, compared to the consensus estimate of $3.00. LivaNova also updated its FY 2024 guidance to 3.050-3.150 EPS. LivaNova Stock Up 2.0 % Shares of LivaNova stock traded up $1.23 […]

Robertw-baird
Barclays
Needham-company
Get-free-report
Moderate-buy
Advanced-circulatory-support
Livanova-daily
Livanova
Nasdaq-livn
Livn
Medical

LivaNova (NASDAQ:LIVN) Issues FY 2024 Earnings Guidance

LivaNova (NASDAQ:LIVN – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 3.050-3.150 for the period, compared to the consensus EPS estimate of 3.000. The company issued revenue guidance of $1.2 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. LivaNova also updated its FY24 […]

Robertw-baird
Needham-company
Barclays
Get-free-report
Moderate-buy
Advanced-circulatory-support
Livanova-daily
Livanova
Nasdaq-livn
Livn
Medical

LivaNova (NASDAQ:LIVN) Releases FY24 Earnings Guidance

LivaNova (NASDAQ:LIVN – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided EPS guidance of $3.05-3.15 for the period, compared to the consensus EPS estimate of $3.00. LivaNova also updated its FY 2024 guidance to 3.050-3.150 EPS. LivaNova Trading Up 2.0 % NASDAQ:LIVN traded up $1.23 during […]

Robertw-baird
Barclays
Nasdaq
Needham-company
Get-free-report
Moderate-buy
Advanced-circulatory-support
Livanova-daily
Livanova
Nasdaq-livn
Livn

LivaNova (NASDAQ:LIVN) PT Raised to $80.00

LivaNova (NASDAQ:LIVN – Get Free Report) had its price target raised by Mizuho from $75.00 to $80.00 in a note issued to investors on Thursday, Benzinga reports. The firm currently has a “buy” rating on the stock. Mizuho’s price objective suggests a potential upside of 27.75% from the company’s current price. A number of other […]

Robertw-baird
Needham-company
Ameriprise-financial-inc
Norges-bank
Barclays
Primecap-management-co
Healthcare-of-ontario-pension-plan-trust-fund
Loomis-sayles-co
Livanova-company-profile
Get-free-report
Ontario-pension-plan-trust-fund

LivaNova (NASDAQ:LIVN) Given New $80.00 Price Target at Mizuho

LivaNova (NASDAQ:LIVN – Get Free Report) had its target price raised by stock analysts at Mizuho from $75.00 to $80.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Mizuho’s price objective indicates a potential upside of 27.75% from the company’s […]

Robertw-baird
Needham-company
Loomis-sayles-co
Norges-bank
Livanova-company-profile
Primecap-management-co
Healthcare-of-ontario-pension-plan-trust-fund
Barclays
Ameriprise-financial-inc
Get-free-report
Ontario-pension-plan-trust-fund

vimarsana © 2020. All Rights Reserved.